Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07160777Active Not Recruiting

Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation

Role: lead

NCT07160764Not Yet Recruiting

Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion

Role: lead

NCT06141018Not ApplicableActive Not Recruiting

Effectiveness and Safety of Intra-articular SEMICAL GEL-B CROSS Therapy in Knee Osteoarthritis (SEM-ART1)

Role: lead

All 3 trials loaded